Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.
2019
11
LTM Revenue $4.1M
LTM EBITDA -$6.4M
-$2.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Lucyd has a last 12-month revenue of $4.1M and a last 12-month EBITDA of -$6.4M.
In the most recent fiscal year, Lucyd achieved revenue of $1.6M and an EBITDA of -$7.6M.
Lucyd expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Lucyd valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $1.2M | $1.6M | XXX | XXX | XXX |
Gross Profit | -$0.1M | -$0.1M | XXX | XXX | XXX |
Gross Margin | -5% | -7% | XXX | XXX | XXX |
EBITDA | -$6.6M | -$7.6M | XXX | XXX | XXX |
EBITDA Margin | -571% | -465% | XXX | XXX | XXX |
Net Profit | -$5.7M | -$6.7M | XXX | XXX | XXX |
Net Margin | -493% | -407% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Lucyd's stock price is $2.
Lucyd has current market cap of $5.2M, and EV of -$2.3M.
See Lucyd trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
-$2.3M | $5.2M | XXX | XXX | XXX | XXX | $-4.39 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Lucyd has market cap of $5.2M and EV of -$2.3M.
Lucyd's trades at -0.6x LTM EV/Revenue multiple, and 0.4x LTM EBITDA.
Analysts estimate Lucyd's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Lucyd and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | -$2.3M | XXX | XXX | XXX |
EV/Revenue | -1.4x | XXX | XXX | XXX |
EV/EBITDA | 0.3x | XXX | XXX | XXX |
P/E | -0.7x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | 0.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpLucyd's NTM/LTM revenue growth is 256%
Lucyd's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.7M for the same period.
Over next 12 months, Lucyd's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Lucyd's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Lucyd and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 42% | XXX | XXX | XXX | XXX |
EBITDA Margin | -465% | XXX | XXX | XXX | XXX |
EBITDA Growth | 16% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | -209% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.7M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 165% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 273% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 50% | XXX | XXX | XXX | XXX |
Opex to Revenue | 497% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lucyd acquired XXX companies to date.
Last acquisition by Lucyd was XXXXXXXX, XXXXX XXXXX XXXXXX . Lucyd acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Lucyd founded? | Lucyd was founded in 2019. |
Where is Lucyd headquartered? | Lucyd is headquartered in United States of America. |
How many employees does Lucyd have? | As of today, Lucyd has 11 employees. |
Who is the CEO of Lucyd? | Lucyd's CEO is Mr. Harrison R. Gross. |
Is Lucyd publicy listed? | Yes, Lucyd is a public company listed on NAS. |
What is the stock symbol of Lucyd? | Lucyd trades under LUCY ticker. |
When did Lucyd go public? | Lucyd went public in 2022. |
Who are competitors of Lucyd? | Similar companies to Lucyd include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Lucyd? | Lucyd's current market cap is $5.2M |
What is the current revenue of Lucyd? | Lucyd's last 12-month revenue is $4.1M. |
What is the current EBITDA of Lucyd? | Lucyd's last 12-month EBITDA is -$6.4M. |
What is the current EV/Revenue multiple of Lucyd? | Current revenue multiple of Lucyd is -0.6x. |
What is the current EV/EBITDA multiple of Lucyd? | Current EBITDA multiple of Lucyd is 0.4x. |
What is the current revenue growth of Lucyd? | Lucyd revenue growth between 2023 and 2024 was 42%. |
Is Lucyd profitable? | Yes, Lucyd is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.